GSSGenetic Signatures Limited

GSS Stock Price, Valuation & Chart | Genetic Signatures Limited

$0.090+0.00 (+0.00%)

At close · 02 Sept 2026, 05:50 am

Sector: Healthcare Industry: Medical - Diagnostics & Research GSS intrinsic value GSS calculated fair value vs price Website

Overview Financials Dividends Ratios

GSS Historical price chart

GSS Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization20.44M

PE Ratio-1.81

EPS-0.05

Trading Volume656.76K

Today's High/Low0.1/0.09

Dividend Yield0.00

52 Week High/Low0.43/0.05

Shares Outstanding227.14M

GSS Financial Statement

GSS Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 1 analyst giving stock ratings to GSS in the past 3 months.

GSS Analysis & performance metrics

GSS Company profile

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It…

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that…

GSS Management team

Name

Position

Karl David PechmannCFO

Chief Financial Officer, Chief Operating Officer & Company Secretary

Rebecca Abbatantuono

Global Head of People & Culture

Rohan Baker

Head of Research & Acting QC Manager

Allison RossiterCEO

Chief Executive Officer

Neralie Coulston B.Sc.

Global Head of Regulatory Affairs

Michael Anton Aicher BSc, M.B.A., MBACTO

Executive Director of US Operations & Executive Director

Christopher M. Abbott A.M., AM, F.C.A., FCA, Ph.D., Ph.D., (Hon)

Founder & Chairman Emeritus

Name

Position

Karl David PechmannCFO

Chief Financial Officer, Chief Operating Officer & Company Secretary

Rebecca Abbatantuono

Global Head of People & Culture

Rohan Baker

Head of Research & Acting QC Manager

Allison RossiterCEO

Chief Executive Officer

Neralie Coulston B.Sc.

Global Head of Regulatory Affairs

Michael Anton Aicher BSc, M.B.A., MBACTO

Executive Director of US Operations & Executive Director

Christopher M. Abbott A.M., AM, F.C.A., FCA, Ph.D., Ph.D., (Hon)

Founder & Chairman Emeritus

Management Team

Karl David PechmannCFO

Chief Financial Officer, Chief Operating Officer & Company Secretary

Rebecca Abbatantuono

Global Head of People & Culture

Rohan Baker

Head of Research & Acting QC Manager

Allison RossiterCEO

Chief Executive Officer

Neralie Coulston B.Sc.

Global Head of Regulatory Affairs

Michael Anton Aicher BSc, M.B.A., MBACTO

Executive Director of US Operations & Executive Director

Christopher M. Abbott A.M., AM, F.C.A., FCA, Ph.D., Ph.D., (Hon)

Founder & Chairman Emeritus

Management

Karl David PechmannCFO

Chief Financial Officer, Chief Operating Officer & Company Secretary

Rebecca Abbatantuono

Global Head of People & Culture

Rohan Baker

Head of Research & Acting QC Manager

Allison RossiterCEO

Chief Executive Officer

Neralie Coulston B.Sc.

Global Head of Regulatory Affairs

Michael Anton Aicher BSc, M.B.A., MBACTO

Executive Director of US Operations & Executive Director

Christopher M. Abbott A.M., AM, F.C.A., FCA, Ph.D., Ph.D., (Hon)

Founder & Chairman Emeritus

Total 7 executives

GSS Frequently asked questions

What is Genetic Signatures Limited (GSS) Stock Price?

Current stock price of Genetic Signatures Limited (GSS) stock is $0.090. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Genetic Signatures Limited (GSS) stock is 656.76K.

Last updated at 02 Sept 2026, 05:50 am.

Why is the Genetic Signatures Limited (GSS) stock price going up or down today?

The stock price of Genetic Signatures Limited (GSS) can change with earnings, company news, and overall market sentiment. Genetic Signatures Limited operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Genetic Signatures Limited stock expensive at its current price?

Whether Genetic Signatures Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GSS on this page is -1.81. EPS on this page is -0.05. Compare those figures with peers and growth expectations before deciding if the current Genetic Signatures Limited price is justified.

How has the stock price of Genetic Signatures Limited (GSS) performed historically?

Historical performance for Genetic Signatures Limited (GSS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GSS reacted to past earnings and market events.

Should I buy Genetic Signatures Limited (GSS) stock, at this price?

Buying Genetic Signatures Limited (GSS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.